Others experience weight loss, but the true transformation is in how the body functions, feels, and remains well
GLP-1 Compounded Medications Targeted by Connecticut Attorney General On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications
However, a previous study illustrated a modest increase in plasma homocysteine levels following the initiation of L-dopa therapy in PD patients (OSuilleabhain et al
Edwards R., Colombo T., Greaves P
GI side effects are common during the initial weeks of treatment and usually improve over time